supplements13 min readApr 16, 2026

Ashwagandha Research Guide: What the Human Trials Actually Show

Comprehensive research guide to ashwagandha (KSM-66). Human clinical trial data on cortisol, sleep, testosterone, strength. Mechanism, dosing research ranges, and honest limitations.

What is Ashwagandha?

Ashwagandha (Withania somnifera) is a small evergreen shrub native to India, the Middle East, and parts of Africa. The root has been used in traditional Ayurvedic medicine for over 3,000 years, where it''s classified as a "rasayana" — loosely translated as a rejuvenative tonic. The Sanskrit name means "smell of horse," referring to both its distinctive aroma and the traditional belief that it conferred the strength of a horse.

The research question: does any of this traditional use hold up to modern clinical scrutiny? As it turns out, ashwagandha is one of the more robustly-studied adaptogens in the human research literature.

Research Status

Ashwagandha has meaningful human clinical trial data — a distinction that separates it from many herbal compounds that are based primarily on traditional use or animal models.

  • Multiple randomized controlled trials (RCTs) published since 2000
  • Cochrane-style reviews have evaluated specific ashwagandha standardized extracts
  • The most-studied extract is KSM-66, a full-spectrum root extract developed specifically for clinical research
  • Other standardized extracts (Sensoril, Shoden) have their own smaller evidence bases

This matters because herbal compounds vary dramatically based on plant part used (root vs. leaf vs. whole plant), extraction method, and standardization. "Ashwagandha" isn''t a single substance — it''s a category, and the clinical evidence attaches to specific standardized extracts.

Mechanism: How It Might Work

The active constituents of ashwagandha are primarily withanolides, a class of steroidal lactones. Standardized extracts like KSM-66 specify withanolide content (typically 5-10% in commercial products).

Research has identified several potential mechanisms:

HPA Axis Modulation

Ashwagandha appears to modulate the hypothalamic-pituitary-adrenal (HPA) axis — the body''s central stress response system. Multiple trials have shown cortisol reduction in ashwagandha-supplemented groups compared to placebo.

GABAergic Activity

Some research suggests ashwagandha constituents may interact with GABA receptors, potentially explaining its anxiolytic effects. This is partially mechanistic hypothesis — the receptor binding is modest compared to pharmaceutical GABAergics.

Thyroid Function

Animal research and some human trials have documented modest thyroid hormone modulation, typically toward normalization (raising T3/T4 in hypothyroid models, lowering in hyperthyroid).

Testosterone and Reproductive Parameters

Several human trials, primarily in male subjects, have shown increases in total testosterone, DHEA-S, and sperm quality markers.

What the Human Trials Show

Cortisol and Stress

The most robust body of evidence:

  • Chandrasekhar et al. (2012): 300mg KSM-66 twice daily for 60 days, n=64 adults with chronic stress. Serum cortisol reduced by ~27.9% vs. placebo. Significant improvements in Perceived Stress Scale and Hamilton Anxiety scores.
  • Lopresti et al. (2019): 240mg Shoden extract for 60 days, n=60. Significant reductions in cortisol, stress, and depression scores.
  • Multiple follow-up trials have replicated stress and cortisol effects, typically in the 20-30% cortisol reduction range.

Sleep

  • Langade et al. (2019): 300mg KSM-66 for 10 weeks, n=60 with insomnia. Improved sleep onset latency, sleep efficiency, total sleep time, and sleep quality vs. placebo.
  • Kelgane et al. (2020): Similar dose and duration. Similar improvements.
  • Effect size is meaningful — comparable to some sleep-specific interventions.

Testosterone and Male Reproductive Health

  • Lopresti et al. (2019, separate trial): 600mg KSM-66 daily for 8 weeks in overweight men aged 40-70. Testosterone increased by 14.7% vs. placebo, DHEA-S by 18%. Self-reported vitality and sexual well-being improved.
  • Ambiye et al. (2013): 675mg KSM-66 in infertile men. Significant improvements in sperm count, motility, and serum testosterone.

Strength and Body Composition

  • Wankhede et al. (2015): 600mg KSM-66 for 8 weeks in young men with resistance training. Increased muscle strength (bench press, leg extension), reduced exercise-induced muscle damage markers, and improved body composition.
  • Several replications have shown similar results in untrained and trained subjects.

Cognitive and Mood

  • Choudhary et al. (2017): Improvements in memory and attention tasks with KSM-66 supplementation.
  • Pratte et al. (2014) systematic review: Suggested modest but consistent anxiolytic effects across multiple trials.

The KSM-66 Distinction

If there''s one thing to understand about ashwagandha research, it''s this: most of the clinical trial data uses KSM-66 specifically, or comparable standardized root extracts.

KSM-66 is a trademarked full-spectrum root extract developed by an Indian company (Ixoreal Biomed) specifically to produce a consistent research-grade material. They''ve funded or facilitated many of the human trials, which is both a strength (consistent material for replication) and a limitation (potential conflict of interest in the trial sponsor).

Practical implication: if you''re comparing ashwagandha products, generic "ashwagandha root powder" hasn''t necessarily been studied in the same way as standardized KSM-66. The product label should specify the extract used.

Molecular Properties

PropertyValue
Scientific nameWithania somnifera
Plant part usedRoot (traditional), leaves (some extracts)
Active compoundsWithanolides, withanosides, sitoindosides
KSM-66 standardization≥5% withanolides
Typical research dose range300-600mg/day
Safety profile (short-term)Generally well-tolerated; GI upset most common

What the Research Doesn''t Yet Show

Honest limitations:

  1. Long-term safety: Most trials are 8-12 weeks. Long-term (years) safety data is limited.
  2. Pregnancy/breastfeeding: Contraindicated in traditional use; no modern trial data.
  3. Autoimmune conditions: Because ashwagandha may modulate immune function, some practitioners advise caution in autoimmune conditions. Trial evidence is limited.
  4. Medication interactions: Possible interactions with thyroid medications, sedatives, immunosuppressants. Research is limited.
  5. Rare hepatotoxicity cases: A small number of case reports have linked ashwagandha to liver injury, though causality is unclear.

Practical Considerations

If you''re researching ashwagandha:

  • Look for standardized extracts: KSM-66, Sensoril, or Shoden — each has specific trial data
  • Research dose range: 300-600mg/day has the most published data
  • Timing: Some research suggests morning + evening dosing splits stress and sleep benefits; other trials use single evening dose. No strong consensus.
  • Duration: Most trials show effects by weeks 4-8. Effects may take 6-8 weeks to peak.
  • Quality markers: Third-party testing (NSF, USP, or similar), specified withanolide content, root-only (not leaf) for most published research

See our full ashwagandha research profile for mechanism details and links.

Where It Fits in a Protocol

Ashwagandha appears in our Stress & Anxiety research protocols and Sleep Optimization protocols. It pairs particularly well with:

  • Magnesium glycinate — complementary sleep and stress mechanisms
  • L-theanine — acute calm + ashwagandha''s chronic stress effects
  • Rhodiola rosea — some practitioners use rhodiola morning + ashwagandha evening as an adaptogen stack

The Bottom Line

Ashwagandha is one of the few herbal compounds with genuinely meaningful human clinical trial data, particularly for stress, cortisol, sleep, and (in men) testosterone. The evidence isn''t pharmaceutical-grade (trial sizes are modest, most are shorter-term, many involve the same commercial extract), but it''s substantial enough to take seriously.

For research purposes: 300-600mg/day of a standardized root extract (KSM-66 being the most-studied) for at least 8 weeks is a reasonable research protocol to investigate, ideally with baseline cortisol, testosterone, and sleep-quality measurements to track individual response.

For research and educational purposes only. Not medical advice. Always consult a qualified healthcare provider.

Want a personalized protocol?

Take the assessment and we'll match you to the right research stack based on your goals.

Start your assessment →
Research disclaimer. All content is for informational and educational purposes only. Products and compounds discussed are for research purposes only. This is not medical advice. Always consult a qualified healthcare provider.